Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
about
Gynecomastia in Patients with Prostate Cancer: A Systematic ReviewGynecomastia: Clinical evaluation and managementEfavirenz directly modulates the oestrogen receptor and induces breast cancer cell growthTamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic reviewMultimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules.Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysisTreatment of bicalutamide-induced breast events.Gynecomastia - evaluation and current treatment optionsIndirect androgen doping by oestrogen blockade in sports.Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.Tamoxifen in men: a review of adverse events.Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines.Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention.Surgical treatment of primary gynecomastia in children and adolescents.The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer.Long-Term Follow-up of Recurrence and Patient Satisfaction After Surgical Treatment of Gynecomastia.Managing Male Mammary Maladies
P2860
Q21131717-225341B8-9BFE-4E96-9097-8316100CCE48Q24568123-4E7E7E13-30B0-466C-B3E5-02DCF92DAF23Q34143084-0D97F865-2874-4DC7-8A36-F33EB305B6A9Q34296202-4F09F988-6F09-4E92-8EE1-1F30C2C20FB9Q34310067-1D5EE1C0-30ED-4201-950F-5FDC8270329DQ34372251-2DB8407F-440C-4050-8F5E-146D93DB5F95Q34722383-98AD5EF8-146D-47AB-808E-193B395DC413Q34764873-1654DE92-CA03-4514-BDA6-CE1160E0536CQ36736110-5EC31858-E3A2-4570-B48C-ADFE23835922Q37028339-2786E544-F4AC-47F7-9840-880C2C94D9B0Q38827549-729E4CBC-28E6-4DC0-8DEA-A9E61E3A2A36Q39591979-862B2F74-0B7E-49D9-9DF9-DD2F36C39BB3Q39663730-072C20B3-7DE9-4670-8918-FE3E04805445Q42656806-5B845AF6-D1F0-47AB-A91C-BC8CB574F7D6Q46682601-82F1D41F-67A0-48E5-9644-568B223546CFQ48141534-21075F7A-7291-42AE-A3FD-3EC76EFA0511Q56003649-65B8B559-21AD-4D2E-A8E2-65BF3A8F1A33
P2860
Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@ast
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@en
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@nl
type
label
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@ast
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@en
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@nl
prefLabel
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@ast
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@en
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@nl
P2093
P1433
P1476
Tamoxifen as prophylaxis for p ...... ntrolled, dose-response study.
@en
P2093
Blair Egerdie
Jon Armstrong
Mahmoud Nachabe
Morten Andersen
Sunil Navani
Teuvo L J Tammela
Thomas Morris
Yves Fradet
P304
P356
10.1016/J.EURURO.2007.01.031
P407
P577
2007-01-16T00:00:00Z